Edesa Biotech, Inc. (EDSA) Operating cash flow 2015–2025
Edesa Biotech, Inc. (EDSA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$7.3MFY2025 · since FY2015: -$4.4M → -$7.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.3M | -49.7% |
| FY2024 | -$4.9M | +26.3% |
| FY2023 | -$6.6M | +46.0% |
| FY2022 | -$12.3M | +10.1% |
| FY2021 | -$13.7M | -174.0% |
| FY2020 | -$5.0M | — |
| FY2018 | -$1.3M | +72.6% |
| FY2017 | -$4.7M | -4.3% |
| FY2016 | -$4.5M | -2.1% |
| FY2015 | -$4.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice